Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sinibaldi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|November 15, 1987
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunctionM J Egorin, B A Conley, A Forrest, et al.
Cancer Research|June 15, 1989
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)B A Conley, A Forrest, M J Egorin, et al.
Seminars in Oncology|December 1, 1996
Prostate cancer treatment strategies based on tumor-specific biological principles: future directionsM A Carducci, T L DeWeese, W G Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancerM Eisenberger, S Krasnow, S Ellenberg, et al.
Investigational New Drugs|July 1, 1992
Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neckF Kruter, M Eisenberger, V Sinibaldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Approaches to optimal dosing of hexamethylene bisacetamideB A Conley, M J Egorin, V Sinibaldi, et al.
Il Giornale Di Chirurgia|January 15, 2011
[Acute abdomen in renal transplant recipients. Epidemiology and treatment in not referral transplantation centers]Gustavo Costa, S M Tierno, F Stella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion scheduleM A Carducci, J Gilbert, M K Bowling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|November 15, 1987
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunctionM J Egorin, B A Conley, A Forrest, et al.
Cancer Research|June 15, 1989
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)B A Conley, A Forrest, M J Egorin, et al.
Seminars in Oncology|December 1, 1996
Prostate cancer treatment strategies based on tumor-specific biological principles: future directionsM A Carducci, T L DeWeese, W G Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancerM Eisenberger, S Krasnow, S Ellenberg, et al.
Investigational New Drugs|July 1, 1992
Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neckF Kruter, M Eisenberger, V Sinibaldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Approaches to optimal dosing of hexamethylene bisacetamideB A Conley, M J Egorin, V Sinibaldi, et al.
Il Giornale Di Chirurgia|January 15, 2011
[Acute abdomen in renal transplant recipients. Epidemiology and treatment in not referral transplantation centers]Gustavo Costa, S M Tierno, F Stella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion scheduleM A Carducci, J Gilbert, M K Bowling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Pageof 2